Announcement • Mar 17
Epibiotech Co., Ltd., Annual General Meeting, Mar 31, 2026 Epibiotech Co., Ltd., Annual General Meeting, Mar 31, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 32, songdogwahak-ro, yeonsu-gu, incheon South Korea New Risk • Sep 10
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (7.6% average weekly change). Market cap is less than US$100m (₩33.0b market cap, or US$23.8m). Announcement • Apr 24
Epibiotech Co., Ltd. announced that it has received KRW 850 million in funding from Korea Investment Partners Co. Ltd. On April 24, 2025 Epibiotech Co., Ltd. closed the transaction.